APAC clean-label trends pivot to 'plus and minus' reformulation, impacting UK brands
Asian Pacific markets are driving clean-label innovation beyond simple ingredient removal, focusing on both 'removing undesirables' and 'adding beneficials', setting a new precedent for UK supplement manufacturers and brand owners.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Singapore, United Kingdom — 07 August 2026
Asian Pacific markets are redefining clean-label expectations, moving beyond the traditional emphasis on simply removing unwanted ingredients. According to Cara Zhuang, Senior Marketing Manager, APAC at Tate & Lyle, a dual 'plus and minus' trend is emerging. This involves simultaneously eliminating undesirable components while actively incorporating nutrients perceived as healthier by consumers. This sophisticated approach to clean labelling is gaining traction across the region, influencing product development and consumer demand.
The shift is evident in products like Zenko's roasted edamame, which leverages naturally nutrient-dense ingredients to meet high-protein and clean-label snack demands. This signifies a broader consumer preference for snacks that combine clear, short ingredient lists with tangible nutritional benefits. The demand for such products is likely to put pressure on UK manufacturers to innovate beyond current clean-label practices, which often focus predominantly on 'free-from' claims.
Alongside this, the influence of GLP-1 receptor agonists is extending beyond North America into the Asia Pacific region, with NIQ Homescan data indicating 78% awareness in Australia and New Zealand, up five percentage points in a quarter. This widespread awareness, coupled with 55% of consumers considering GLP-1 drug usage, suggests a growing market for 'GLP-1 friendly' nutritional products. While not directly related to clean label, this trend underscores the rapid evolution of consumer health priorities and the need for agile product development.
Separately, regulatory approvals for cultivated meat, such as Aleph Farms' cultivated beef steak in Singapore, highlight the pace of food technology innovation and the importance of adapting to new ingredient possibilities and consumer ethics. While a distinct category, the regulatory agility demonstrated by Singapore's Food Agency (SFA) sets a precedent for how novel ingredients, including those relevant to supplements, could be evaluated and approved.
What this means for United Kingdom
UK supplement manufacturers and brand owners must recognise that APAC's advanced clean-label standards will inevitably influence global consumer expectations. Compliance teams should begin assessing how current formulations align with a 'plus and minus' strategy, focusing on ingredient provenance and added value. Reformulation windows for key product lines should be scheduled within the next 12-18 months to integrate these new principles, particularly for products targeting export markets or higher-value domestic segments. Procurement leads will need to identify and vet suppliers capable of providing high-quality, traceable, and functionally beneficial ingredients. Brands failing to adapt risk being perceived as less innovative and potentially losing market share to more agile competitors who can articulate both what their products are 'free from' and what beneficial ingredients they contain.
Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.